Profil
K.
Chris Min worked as a Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and as VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min completed his undergraduate degree at Harvard University and earned his doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Anciens postes connus de K. Min
Sociétés | Poste | Fin |
---|---|---|
LONGEVERON INC. | Chief Executive Officer | 01/03/2023 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Formation de K. Min
Harvard University | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Bluerock Therapeutics, Inc. |